Výsledky vyhledávání

Varying Rates of Clostridium Difficile-Associated Diarrhea at Prevention Epicenter Hospitals

Autor: Trish M. Perl, Edward S. Wong, Jerome I. Tokars, David K. Warren, Daniel J. Diekema, Victoria J. Fraser, Xiaoyan Song, Loreen A. Herwaldt, Theresa Zembower, Deborah S. Yokoe, Michael W. Climo, Sejean Sohn, Gary A. Noskin, Kent A. Sepkowitz, Susan E. Marino

Publikováno v: Infection Control & Hospital Epidemiology. 26:676-679

Background:Clostridium difficile-associated diarrhea (CDAD) causes substantial healthcare-associated morbidity. Unlike other common healthcare-associated pathogens, little comparative information is available about CDAD rates in hospitalized patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4c9c0b92e1dd6f6ab6ccdd9e47bdb60
https://doi.org/10.1086/502601

Zobrazit plný text záznamu

Risk Factors for Acquisition of Clostridium difficile–Associated Diarrhea among Outpatients at a Cancer Hospital

Autor: Janet Eagan, Tara N. Palmore, Sejean Sohn, Sharp F. Malak, Kent A. Sepkowitz

Publikováno v: Infection Control & Hospital Epidemiology. 26:680-684

Background:Clostridium difficile-associated diarrhea (CDAD) is an important infection in hospital settings. Its impact on outpatient care has not been well defined.Objective:To examine risk factors of ambulatory cancer patients with CDAD.Design:Case-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d4fedea9a6da187800df89cfb217837
https://doi.org/10.1086/502602

Zobrazit plný text záznamu

Effect of Implementing Safety-Engineered Devices on Percutaneous Injury Epidemiology

Autor: Kent A. Sepkowitz, Sejean Sohn, Janet Eagan, Gianna Zuccotti

Publikováno v: Infection Control & Hospital Epidemiology. 25:536-542

Objective:To assess the effect of implementing safety-engineered devices on percutaneous injury epidemiology, specifically on percutaneous injuries associated with a higher risk of blood-borne pathogen exposure.Design:Before-and-after intervention tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c30401ff7ad35333b7bba22fb2bcadd5
https://doi.org/10.1086/502436

Zobrazit plný text záznamu

Safety-Engineered Device Implementation: Does It Introduce Bias in Percutaneous Injury Reporting?

Autor: Kent A. Sepkowitz, Janet Eagan, Sejean Sohn

Publikováno v: Infection Control & Hospital Epidemiology. 25:543-547

Objective:To examine whether implementation of safety-engineered devices in 2001 had an effect on rates of percutaneous injury (PI) reported by HCWs.Design:Before-and-after intervention trial comparing 3-year preintervention (1998–2001) and 2-year

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1789f21d0ac5716e7f8a3df6a5753598
https://doi.org/10.1086/502437

Zobrazit plný text záznamu

Financial Impact of Coagulase-Negative Staphylococcal (CoNS) Bacteremia at a Cancer Hospital

Autor: Gianna Zuccotti, Manisha Juthani-Mehta, Sejean Sohn, Susan K. Seo, Janet Eagan, Paul Bernstein, Kent A. Sepkowitz

Publikováno v: Epidemiology: Open Access.

Objective: To determine the financial impact of Coagulase-Negative Staphylococcus (CoNS)- positive blood cultures. Design: Retrospective chart review. Setting: Tertiary care cancer hospital. Patients: All episodes of CoNS bacteremia during the first

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::26a36de9de726191aead6435b2063229
https://doi.org/10.4172/2161-1165.1000147

Zobrazit plný text záznamu

Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications

Autor: Carolyn J. Quinn, Philip O. Livingston, Paul B. Chapman, Y. B. Su, Linda Williams, Sejean Sohn, Kent A. Sepkowitz, Jedd D. Wolchok, Susan E. Krown, Theresa Foster

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 22(4)

Purpose Standard schedule temozolomide (TMZ; daily for 5 days every 4 weeks) is often used in melanoma patients, but phase III data show that it is no more effective than standard dacarbazine. Extended TMZ dosing regimens may be superior by deliverin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d98c20ae412ebc14963673b54028fb4d
https://pubmed.ncbi.nlm.nih.gov/15961774

Zobrazit plný text záznamu

Serum IL-12:IL-6 Ratio Reliably Distinguishes Infectious from Non-Infectious Causes of Fever during Autologous Stem Cell Transplantation (ASCT)

Autor: David Galinkin, Eric G. Pamer, R.D. Rice, Tarun Kewalramani, Jing Qin, Melissa Blain, Sejean Sohn, Nikolaos G. Almyroudis, Roman A. Tuma, Stephen D. Nimer

Publikováno v: Blood. 104:353-353

Fever occurs commonly in patients (pts) undergoing ASCT, both during neutropenia and after neutrophil engraftment, but infectious etiologies are infrequently identified. A reliable and rapid method to distinguish infectious from non-infectious etiolo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c8dd754b299de65b99dd924da91d18c5
https://doi.org/10.1182/blood.v104.11.353.353

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání